SCHEMBL339757

SCHEMBL339757

NCC(CS(=O)(=O)O)c1ccc(Cl)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABBR2 O75899 6/20 1.00
GABBR1 Q9UBS5 6/20 1.00
LMNA P02545 3/20 0.57
CYP1A2 P05177 3/20 0.57
CYP2C9 P11712 2/20 0.57
THRB P10828 2/20 0.57
CYP3A4 P08684 2/20 0.57
TSHR P16473 2/20 0.57
ADORA3 P0DMS8 1/20 0.57
NFKB1 P19838 1/20 0.57
DRD3 P35462 1/20 0.57
BLM P54132 1/20 0.57
CYP2D6 P10635 1/20 0.57
CYP2C19 P33261 1/20 0.57
MEN1 O00255 1/20 0.57
KMT2A Q03164 1/20 0.57
MAPT P10636 2/20 0.56
PMP22 Q01453 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL339758 1.00 GABBR2 (1.00) GABBR2GABBR1LMNACYP1A2CYP2C9
SCHEMBL28968674 1.00 GABBR2 (1.00) GABBR2GABBR1LMNACYP1A2CYP2C9
SCHEMBL4601734 0.81 GABBR2 (0.69) GABBR2GABBR1LMNACYP1A2CYP2C9
SCHEMBL23082612 0.78 GABBR2 (0.64) GABBR2GABBR1LMNACYP1A2CYP2C9
SCHEMBL1055044 0.78 GABBR2 (0.64) GABBR2GABBR1LMNACYP1A2CYP2C9
SCHEMBL10507284 0.78 GABBR2 (0.64) GABBR2GABBR1LMNACYP1A2CYP2C9
SCHEMBL6032624 0.78 GABBR2 (0.64) GABBR2GABBR1LMNACYP1A2CYP2C9
Hydrochloric Acid SCHEMBL10681987 0.76 GABBR2 (0.62) GABBR2GABBR1LMNACYP1A2CYP2C9
SCHEMBL7396004 0.75 GABBR2 (0.61) GABBR2GABBR1LMNACYP1A2CYP2C9
SCHEMBL9779274 0.75 GABBR2 (0.61) GABBR2GABBR1LMNACYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 465 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12046756-B2 Cellulose derivative composition for secondary battery binder and method of preparing composition for secondary battery electrode comprising the same ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE (KR) 2024-07-23 US claimed
US-20240142377-A1 DYES UNDERGOING CHANGES IN COLOR AND FLUORESCENCE UPON BINDING OF ORGANIC OXO COMPOUNDS BUNDESREPUBLIK DEUTSCHLAND, VERTRETEN DURCH DEN BUNDESMINISTER FÜR WIRTSCHAFT UND ENERGIE, DIESER VE (DE) 2024-05-02 US claimed
EP-4255897-A1 DYES UNDERGOING CHANGES IN COLOR AND FLUORESCENCE UPON BINDING OF ORGANIC OXO COMPOUNDS Bundesrepublik Deutschland, vertreten durch den Bundesminister für Wirtschaft und Energie, dieser vertreten durch den Präsidenten der (DE) 2023-10-11 EP claimed
WO-2022122402-A1 DYES UNDERGOING CHANGES IN COLOR AND FLUORESCENCE UPON BINDING OF ORGANIC OXO COMPOUNDS BUNDESREPUBLIK DEUTSCHLAND, VERTRETEN DURCH DEN BUNDESMINISTER FÜR WIRTSCHAFT UND ENERGIE, DIESER VERTRETEN DURCH DEN PRÄSIDENTEN DER BUNDESANSTALT FÜR MATERIALFORSCHUNG UND -PRÜFUNG, (BAM) (DE) 2022-06-16 WO claimed
US-20220140346-A1 CELLULOSE DERIVATIVE COMPOSITION FOR SECONDARY BATTERY BINDER AND METHOD OF PREPARING COMPOSITION FOR SECONDARY BATTERY ELECTRODE COMPRISING THE SAME DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2022-05-05 US claimed
US-20220131150-A1 CELLULOSE DERIVATIVE COMPOSITION FOR SECONDARY BATTERY BINDER AND METHOD OF PREPARING COMPOSITION FOR SECONDARY BATTERY ELECTRODE COMPRISING THE SAME ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE (KR) 2022-04-28 US claimed
US-10716779-B2 Methods and compositions for treating foot or hand pain SANDERS JENNIFER L (US) 2020-07-21 US claimed
US-20190083465-A1 Methods And Compositions For Treating Foot Or Hand Pain SANDERS JENNIFER L (US) 2019-03-21 US claimed
US-10195180-B2 Methods and compositions for treating foot or hand pain SANDERS JENNIFER L (US) 2019-02-05 US claimed
WO-2017089804-A1 NOVEL PHARMACEUTICAL COMPOSITIONS OXFORD UNIVERSITY INNOVATION LIMITED (GB) 2017-06-01 WO claimed
EP-0701438-B1 GABA-ERGIC MODULATION OF EYE GROWTH UNIV PENNSYLVANIA (US) 1999-07-07 EP claimed
EP-0701438-A4 GABA-ERGIC MODULATION OF EYE GROWTH UNIV PENNSYLVANIA (US) 1997-11-19 EP claimed
US-5587509-A Caged caboxyl compounds and use thereof CORNELL RESEARCH FOUNDATION, INC. (US) 1996-12-24 US claimed
US-5567731-A Gaba-ergic modulation of eye growth THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1996-10-22 US claimed
CN-1122104-A Gaba-Ergic modulation of eye growth UNIV PENNSYLVANIA (US) 1996-05-08 CN claimed
EP-0701438-A1 GABA-ERGIC MODULATION OF EYE GROWTH THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1996-03-20 EP claimed
US-5430175-A Caged carboxyl compounds and use thereof CORNELL RESEARCH FOUNDATION, INC. (US) 1995-07-04 US claimed
WO-1995015305-A1 CAGED CARVOXYL COMPOUNDS AND THEIR USE IN CHEMICAL KINETIC INVESTIGATION OF NEUROTRANSMITTER RECEPTORS CORNELL RESEARCH FOUNDATION, INC. (US) 1995-06-08 WO claimed
US-5385939-A Preventing the axial elongation myopia in the eye by administering a gama-aminobutyric acid receptor antagonist THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1995-01-31 US claimed
WO-1994025018-A1 GABA-ERGIC MODULATION OF EYE GROWTH THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1994-11-10 WO claimed